HR+ Breast Cancer Clinical Trials

7 clinical trials for HR+ Breast Cancer across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
• Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) . — RECRUITING
• SHR-A1811 Plus Pertuzumab as Neoadjuvant Therapy for Early or Locally Advanced HR-Positive HER2-Positive Breast Cancer: A Prospective, Open-Label, Phase II Study — NOT_YET_RECRUITING · PHASE2
• Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer — NOT_YET_RECRUITING · PHASE3
• (VELA) Study of BLU-222 in Advanced Solid Tumors — TERMINATED · PHASE1
• SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers — NOT_YET_RECRUITING · PHASE2

Refine this search